Stifel Financial’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.36M | Sell |
70,482
-631
| -0.9% | -$12.4K | ﹤0.01% | 2235 |
|
|
2025
Q4 | $1.35M | Sell |
71,113
-1,414
| -2% | -$26.2K | ﹤0.01% | 2240 |
|
|
2025
Q3 | $1.35M | Buy |
72,527
+2,891
| +4% | +$54K | ﹤0.01% | 2186 |
|
|
2025
Q2 | $1.28M | Buy |
69,636
+24,684
| +55% | +$438K | ﹤0.01% | 2156 |
|
|
2025
Q1 | $785K | Buy |
44,952
+7,416
| +20% | +$125K | ﹤0.01% | 2387 |
|
|
2024
Q4 | $650K | Sell |
37,536
-463,722
| -93% | -$8.47M | ﹤0.01% | 2526 |
|
|
2024
Q3 | $9.33M | Sell |
501,258
-113,245
| -18% | -$1.91M | 0.01% | 873 |
|
|
2024
Q2 | $9.46M | Sell |
614,503
-13,900
| -2% | -$199K | 0.01% | 832 |
|
|
2024
Q1 | $9.28M | Sell |
628,403
-43,824
| -7% | -$607K | 0.01% | 845 |
|
|
2023
Q4 | $9.59M | Buy |
672,227
+68,238
| +11% | +$969K | 0.01% | 785 |
|
|
2023
Q3 | $8.42M | Buy |
603,989
+27,610
| +5% | +$353K | 0.01% | 787 |
|
|
2023
Q2 | $6.78M | Buy |
576,379
+4,734
| +0.8% | +$53.9K | 0.01% | 891 |
|
|
2023
Q1 | $6.57M | Buy |
571,645
+508,339
| +803% | +$6.29M | 0.01% | 866 |
|
|
2022
Q4 | $787K | Sell |
63,306
-634,654
| -91% | -$8.09M | ﹤0.01% | 2177 |
|
|
2022
Q3 | $9.16M | Sell |
697,960
-115
| -0% | -$1.7K | 0.02% | 666 |
|
|
2022
Q2 | $9.75M | Buy |
698,075
+117,145
| +20% | +$1.57M | 0.02% | 659 |
|
|
2022
Q1 | $8.65M | Buy |
580,930
+60,924
| +12% | +$834K | 0.01% | 783 |
|
|
2021
Q4 | $7.04M | Buy |
520,006
+367,152
| +240% | +$5.2M | 0.01% | 897 |
|
|
2021
Q3 | $2.25M | Buy |
152,854
+133,865
| +705% | +$2.26M | ﹤0.01% | 1498 |
|
|
2021
Q2 | $346K | Buy |
18,989
+8,191
| +76% | +$146K | ﹤0.01% | 2804 |
|
|
2021
Q1 | $187K | Buy |
10,798
+332
| +3% | +$5.84K | ﹤0.01% | 3033 |
|
|
2020
Q4 | $182K | Sell |
10,466
-1,278
| -11% | -$20.4K | ﹤0.01% | 2842 |
|
|
2020
Q3 | $162K | Buy |
11,744
+820
| +8% | +$12K | ﹤0.01% | 2664 |
|
|
2020
Q2 | $157K | Sell |
10,924
-14,474
| -57% | -$190K | ﹤0.01% | 2640 |
|
|
2020
Q1 | $277K | Sell |
25,398
-50,692
| -67% | -$935K | ﹤0.01% | 2237 |
|
|
2019
Q4 | $1.62M | Buy |
76,090
+65,118
| +593% | +$1.46M | ﹤0.01% | 1469 |
|
|
2019
Q3 | $253K | Buy |
10,972
+298
| +3% | +$6.36K | ﹤0.01% | 2534 |
|
|
2019
Q2 | $210K | Sell |
10,674
-5,350
| -33% | -$104K | ﹤0.01% | 2690 |
|
|
2019
Q1 | $313K | Sell |
16,024
-31,863
| -67% | -$604K | ﹤0.01% | 2334 |
|
|
2018
Q4 | $791K | Sell |
47,887
-3,110
| -6% | -$62.6K | ﹤0.01% | 1684 |
|
|
2018
Q3 | $1.18M | Sell |
50,997
-24,066
| -32% | -$545K | ﹤0.01% | 1569 |
|
|
2018
Q2 | $1.62M | Sell |
75,063
-786,627
| -91% | -$15.4M | 0.01% | 1323 |
|
|
2018
Q1 | $15.2M | Buy |
861,690
+456,488
| +113% | +$8.05M | 0.05% | 382 |
|
|
2017
Q4 | $7.6M | Buy |
405,202
+374,865
| +1,236% | +$7.46M | 0.02% | 618 |
|
|
2017
Q3 | $663K | Buy |
+30,337
| New | +$685K | ﹤0.01% | 1720 |
|
|
2017
Q2 | – | Sell |
-8,022
| Closed | -$225K | – | 2610 |
|
|
2017
Q1 | $225K | Sell |
8,022
-2,006
| -20% | -$52.6K | ﹤0.01% | 2260 |
|
|
2016
Q4 | $247K | Sell |
10,028
-6,433
| -39% | -$147K | ﹤0.01% | 2148 |
|
|
2016
Q3 | $414K | Buy |
+16,461
| New | +$394K | ﹤0.01% | 1821 |
|
|
2016
Q1 | – | Sell |
-12,085
| Closed | -$245K | – | 2361 |
|
|
2015
Q4 | $245K | Sell |
12,085
-10,554
| -47% | -$222K | ﹤0.01% | 2019 |
|
|
2015
Q3 | $525K | Buy |
22,639
+1,743
| +8% | +$44.5K | ﹤0.01% | 1525 |
|
|
2015
Q2 | $536K | Buy |
20,896
+7,821
| +60% | +$222K | ﹤0.01% | 1658 |
|
|
2015
Q1 | $433K | Buy |
+13,075
| New | +$424K | ﹤0.01% | 1693 |
|
Other funds holding SBRA
VPM
VCM
N
Stifel Financial's SBRA Position: Q1 2026 in Review
Stifel Financial reduced its Sabra Healthcare REIT (SBRA) stake by 0.89% in Q1 2026, selling an estimated $12.4K and leaving 70,482 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #2235.
Stifel Financial first reported a position in SBRA in Q1 2015 and has held it in 42 quarters since. The position peaked at $15.2M in Q1 2018. 459 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.
- Stifel Financial held 70,482 shares of Sabra Healthcare REIT worth $1.36M as of Q1 2026.
- Stifel Financial sold 631 Sabra Healthcare REIT shares in Q1 2026, an estimated $12.4K.
- Sabra Healthcare REIT made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #2235 holding.
- Stifel Financial first reported a position in Sabra Healthcare REIT in Q1 2015 and has held it in 42 quarters since.
- Stifel Financial's Sabra Healthcare REIT position peaked at $15.2M in Q1 2018.
- 459 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.
Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.